A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1186/s12885-015-1606-1
Published Online: 2015-08-27
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamaguchi, Kazuhisa
Taniguchi, Hiroya
Komori, Azusa
Narita, Yukiya
Nitta, Sohei
Nomura, Motoo
Kadowaki, Shigenori
Takahari, Daisuke
Ura, Takashi
Andoh, Masashi
Muro, Kei
Mori, Keita
Igarashi, Yoshinori
License valid from 2015-08-27